发明名称 USE OF PTHRP ANTAGONISTS FOR TREATING RENAL CELL CARCINOMA
摘要 <p>The invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumor growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.</p>
申请公布号 WO2004004756(A1) 申请公布日期 2004.01.15
申请号 WO2003FR02084 申请日期 2003.07.04
申请人 UNIVERSITE LOUIS PASTEUR;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);HOPITAUX UNIVERSITAIRES DE STRASBOURG;MASSFELDER, THIERRY;LANG, HERVE;SCHORDAN, ERIC;HELWIG, JEAN-JACQUES 发明人 MASSFELDER, THIERRY;LANG, HERVE;SCHORDAN, ERIC;HELWIG, JEAN-JACQUES
分类号 A61K38/17;A61K38/29;A61P35/00;C07K16/26;(IPC1-7):A61K38/29;A61K39/395 主分类号 A61K38/17
代理机构 代理人
主权项
地址